Skip to content
OpenCapital
Get started

Illumina ILMN Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$164M+157%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$35.86M-20.7%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$10.94M-60.6%
Revvity logo
RevvityRVTY
——
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$29.2B+69.7%
Enterprise value$30.1B+63.8%
P/E35.4×+21.7×
P/S6.5×+2.5×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%—
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Illumina’s 8-K, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's cash provided by (used in) investing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's cash provided by (used in) investing activity, including discontinued operation?
Illumina (ILMN) reported cash provided by (used in) investing activity, including discontinued operation of -$121M in Q2 2026.
How has Illumina's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
Illumina's cash provided by (used in) investing activity, including discontinued operation decreased by 146.9% year-over-year, from -$49M to -$121M.
What is the long-term trend for Illumina's cash provided by (used in) investing activity, including discontinued operation?
Over 3 years (2021 to 2024), Illumina's cash provided by (used in) investing activity, including discontinued operation has grown at a -45.0% compound annual growth rate (CAGR), from -$1.07B to -$178M.
What does cash provided by (used in) investing activity, including discontinued operation mean?
The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.